{"id":1260,"date":"2023-07-12T11:09:56","date_gmt":"2023-07-12T09:09:56","guid":{"rendered":"https:\/\/centrosviluppofarmaci-opbg.it\/trial\/wa42985-posterity-2\/"},"modified":"2023-07-12T11:09:56","modified_gmt":"2023-07-12T09:09:56","slug":"wa42985-posterity-2","status":"finished","type":"trial","link":"https:\/\/centrosviluppofarmaci-opbg.it\/en\/trial\/wa42985-posterity-2\/","title":{"rendered":"WA42985 Posterity"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">A Phase Ii, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study To Evaluate The Efficacy, Safety, And Pharmacokinetics Of Obinutuzumab When Given In Combination With Mycophenolate Mofetil And Corticosteroids In Adolescent Participants With Active Class Iii Or Iv Lupus Nephritis<\/p>\n","protected":false},"excerpt":{"rendered":"<p>A Phase Ii, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study To Evaluate The Efficacy, Safety, And Pharmacokinetics Of Obinutuzumab When Given In Combination With Mycophenolate Mofetil And Corticosteroids In Adolescent Participants With Active Class Iii Or Iv Lupus Nephritis<\/p>\n","protected":false},"author":3,"featured_media":0,"menu_order":0,"template":"","meta":{"footnotes":""},"trials_category":[],"scope":[46],"class_list":["post-1260","trial","type-trial","status-finished","hentry","scope-neurology"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>WA42985 Posterity - Centro Sviluppo Farmaci<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/centrosviluppofarmaci-opbg.it\/en\/trial\/wa42985-posterity-2\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"WA42985 Posterity - Centro Sviluppo Farmaci\" \/>\n<meta property=\"og:description\" content=\"A Phase Ii, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study To Evaluate The Efficacy, Safety, And Pharmacokinetics Of Obinutuzumab When Given In Combination With Mycophenolate Mofetil And Corticosteroids In Adolescent Participants With Active Class Iii Or Iv Lupus Nephritis\" \/>\n<meta property=\"og:url\" content=\"https:\/\/centrosviluppofarmaci-opbg.it\/en\/trial\/wa42985-posterity-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Centro Sviluppo Farmaci\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/centrosviluppofarmaci-opbg.it\\\/en\\\/trial\\\/wa42985-posterity-2\\\/\",\"url\":\"https:\\\/\\\/centrosviluppofarmaci-opbg.it\\\/en\\\/trial\\\/wa42985-posterity-2\\\/\",\"name\":\"WA42985 Posterity - Centro Sviluppo Farmaci\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/centrosviluppofarmaci-opbg.it\\\/en\\\/#website\"},\"datePublished\":\"2023-07-12T09:09:56+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/centrosviluppofarmaci-opbg.it\\\/en\\\/trial\\\/wa42985-posterity-2\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/centrosviluppofarmaci-opbg.it\\\/en\\\/trial\\\/wa42985-posterity-2\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/centrosviluppofarmaci-opbg.it\\\/en\\\/trial\\\/wa42985-posterity-2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/centrosviluppofarmaci-opbg.it\\\/en\\\/homepage\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"WA42985 Posterity\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/centrosviluppofarmaci-opbg.it\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/centrosviluppofarmaci-opbg.it\\\/en\\\/\",\"name\":\"Centro Sviluppo Farmaci\",\"description\":\"Insieme, facciamo crescere l\u2019innovazione.\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/centrosviluppofarmaci-opbg.it\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"WA42985 Posterity - Centro Sviluppo Farmaci","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/centrosviluppofarmaci-opbg.it\/en\/trial\/wa42985-posterity-2\/","og_locale":"en_US","og_type":"article","og_title":"WA42985 Posterity - Centro Sviluppo Farmaci","og_description":"A Phase Ii, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study To Evaluate The Efficacy, Safety, And Pharmacokinetics Of Obinutuzumab When Given In Combination With Mycophenolate Mofetil And Corticosteroids In Adolescent Participants With Active Class Iii Or Iv Lupus Nephritis","og_url":"https:\/\/centrosviluppofarmaci-opbg.it\/en\/trial\/wa42985-posterity-2\/","og_site_name":"Centro Sviluppo Farmaci","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/centrosviluppofarmaci-opbg.it\/en\/trial\/wa42985-posterity-2\/","url":"https:\/\/centrosviluppofarmaci-opbg.it\/en\/trial\/wa42985-posterity-2\/","name":"WA42985 Posterity - Centro Sviluppo Farmaci","isPartOf":{"@id":"https:\/\/centrosviluppofarmaci-opbg.it\/en\/#website"},"datePublished":"2023-07-12T09:09:56+00:00","breadcrumb":{"@id":"https:\/\/centrosviluppofarmaci-opbg.it\/en\/trial\/wa42985-posterity-2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/centrosviluppofarmaci-opbg.it\/en\/trial\/wa42985-posterity-2\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/centrosviluppofarmaci-opbg.it\/en\/trial\/wa42985-posterity-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/centrosviluppofarmaci-opbg.it\/en\/homepage\/"},{"@type":"ListItem","position":2,"name":"WA42985 Posterity"}]},{"@type":"WebSite","@id":"https:\/\/centrosviluppofarmaci-opbg.it\/en\/#website","url":"https:\/\/centrosviluppofarmaci-opbg.it\/en\/","name":"Centro Sviluppo Farmaci","description":"Insieme, facciamo crescere l\u2019innovazione.","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/centrosviluppofarmaci-opbg.it\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"acf":{"related_news":null},"card_html":"\n<div class=\"card card-trial\">\n    <div class=\"card-body\">\n        <h4 class=\"card-title\">WA42985 Posterity<\/h4>\n        <p>A Phase Ii, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study To Evaluate The Efficacy, Safety, And Pharmacokinetics Of Obinutuzumab When Given In Combination With Mycophenolate Mofetil And Corticosteroids In Adolescent Participants With Active Class Iii Or Iv Lupus Nephritis<\/p>\n                <a href=\"https:\/\/centrosviluppofarmaci-opbg.it\/en\/trial\/wa42985-posterity-2\/\" title=\"Show more\" class=\"link-secondary\">\n            <svg class=\"icon\"><use xlink:href=\"https:\/\/centrosviluppofarmaci-opbg.it\/wp-content\/themes\/csf\/assets\/dist\/svg\/sprite-icon.svg#icon-arrow-right\"><\/use><\/svg>\n        <\/a>\n    <\/div>\n    <div class=\"card-footer d-grid gap-2\">\n\t    \t            <button class=\"btn btn-outline-secondary\" data-bs-toggle=\"modal\" data-bs-target=\"#contactIModal\" data-bs-trial=\"WA42985 Posterity\">\n\t\t    Contact us for information        <\/button>\n\t        <\/div>\n<\/div>\n","_links":{"self":[{"href":"https:\/\/centrosviluppofarmaci-opbg.it\/en\/wp-json\/wp\/v2\/trial\/1260","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/centrosviluppofarmaci-opbg.it\/en\/wp-json\/wp\/v2\/trial"}],"about":[{"href":"https:\/\/centrosviluppofarmaci-opbg.it\/en\/wp-json\/wp\/v2\/types\/trial"}],"author":[{"embeddable":true,"href":"https:\/\/centrosviluppofarmaci-opbg.it\/en\/wp-json\/wp\/v2\/users\/3"}],"version-history":[{"count":0,"href":"https:\/\/centrosviluppofarmaci-opbg.it\/en\/wp-json\/wp\/v2\/trial\/1260\/revisions"}],"wp:attachment":[{"href":"https:\/\/centrosviluppofarmaci-opbg.it\/en\/wp-json\/wp\/v2\/media?parent=1260"}],"wp:term":[{"taxonomy":"trials_category","embeddable":true,"href":"https:\/\/centrosviluppofarmaci-opbg.it\/en\/wp-json\/wp\/v2\/trials_category?post=1260"},{"taxonomy":"scope","embeddable":true,"href":"https:\/\/centrosviluppofarmaci-opbg.it\/en\/wp-json\/wp\/v2\/scope?post=1260"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}